Stimuli-Responsive Polymers and Their Applications in Nanomedicine by Etienne Cabane et al.
IN FOCUS: NANOMEDICINE - REVIEW
Stimuli-Responsive Polymers and Their Applications
in Nanomedicine
Etienne Cabane • Xiaoyan Zhang • Karolina Langowska •
Cornelia G. Palivan • Wolfgang Meier
Received: 17 October 2011 / Accepted: 29 November 2011 / Published online: 11 February 2012
 The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract This review focuses on smart nano-materials
built of stimuli-responsive (SR) polymers and will discuss
their numerous applications in the biomedical field. The
authors will first provide an overview of different stimuli
and their corresponding, responsive polymers. By intro-
ducing myriad functionalities, SR polymers present a wide
range of possibilities in the design of stimuli-responsive
devices, making use of virtually all types of polymer
constructs, from self-assembled structures (micelles, vesi-
cles) to surfaces (polymer brushes, films) as described in
the second section of the review. In the last section of this
review the authors report on some of the most promising
applications of stimuli-responsive polymers in nanomedi-
cine. In particular, we will discuss applications pertaining
to diagnosis, where SR polymers are used to construct
sensors capable of selective recognition and quantification
of analytes and physical variables, as well as imaging
devices. We will also highlight some examples of
responsive systems used for therapeutic applications,
including smart drug delivery systems (micelles, vesicles,
dendrimers …) and surfaces for regenerative medicine.
1 Introduction
Challenges confronted by medicine today include the
increasing demand for sensitive, efficient systems and
approaches that will improve responses to pathology. In
this respect, for detection purposes, there is a need for new
agents that will simultaneously increase sensitivity while
their concentrations in the body decrease to avoid accu-
mulation and side-effects. Such agents are intended to
efficiently detect pathological conditions in their early
stages or distinguish slight changes in areas where surgery
has been done, serving to enhance prognoses, especially in
complex diseases such as cancer, HIV, and degenerative
diseases. The necessity of decreasing doses while increas-
ing efficacy is essential for therapeutic approaches, while
decreased side effects will improve a patient’s condition,
especially in chronic disease or diseases requiring the
administration of toxic compounds, for example cancer or
HIV. The design of new systems and approaches must meet
challenges associated with administration in the body: (i) a
simple route of administration, (ii) effective delivery to the
desired biological compartment, (iii) response adapted to
the pathological event, either rapid or slow, depending on
the bio-specificity, and (iv) the use of non-toxic, biocom-
patible and biodegradable systems. Current know-how in
nanotechnology is making possible new ways to fight a
number of diseases. As the development of the fast grow-
ing field known as nanomedicine employs nanostructures
and nanodevices to diagnose, treat, and prevent diseases
[1]. In this respect, nanoscience offers novel systems and
methods for medical use by providing carriers such as
particles, micelles, dendrimers, and vesicles to transport
active compounds (drugs, contrast agents, proteins, DNA),
and ‘‘active’’ surfaces adapted to biosensing, regeneration
and wound healing, An efficient way to improve these
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systems is to make them stimuli-responsive. A smart
response to external or internal stimuli allows: (i) better
localization of the system in the desired biological com-
partment, (ii) controlled release of payload at the location
of the pathological event, and (iii) rapidly addressing/
imaging the pathological event. In particular, polymers
have proven themselves clever options in developing
stimuli-responsive systems because their chemistry permits
modulating the properties by including responsiveness via
sensitive chemical moieties. A large variety of polymers/
copolymers has been synthesized to response to physical
stimuli (temperature, pH, light), chemical stimuli (various
‘‘signaling’’ molecules), or biological stimuli (enzymes).
Stimuli-responsive polymers undergo dramatic and abrupt
physical and chemical changes in response to external
stimuli [2]. They are also termed ‘smart-’ [3, 4], ‘intelli-
gent-’ [5], or ‘environmentally sensitive’ polymers [6]. One
important feature of this type of material is reversibility,
i.e. the ability of the polymer to return to its initial state
upon application of a counter-trigger. In nature, biopoly-
mers such as proteins and nucleic acids are all basic
stimuli-responsive components of living organic systems
and often remain stable over wide ranges of external
variables but undergo drastic conformational changes
abruptly at given critical points [3, 7]. These ‘natural’
stimuli-responsive polymers have led to the development
of numerous synthetic polymers that have been designed to
mimic their adaptive behaviours.
By incorporating functional groups that are amenable to
a change in character (e.g. charge, polarity and solvency)
along a polymer backbone, the resulting relative changes in
chemical structure will be amplified synergistically, lead-
ing to dramatic transformations in macroscopic material
properties. Typically, the ‘response’ of a polymer in solu-
tion alters its individual chain dimensions/size, secondary
structure, solubility, or the degree of intermolecular asso-
ciation [8]. In most cases, the present or destruction of
secondary forces (hydrogen bonding, hydrophobic effects,
electrostatic interactions, etc.), simple reactions (e.g., acid–
base reactions) of moieties linked to the polymer backbone,
and/or osmotic pressure differences are responsible for this
response. Another type of ‘response’ is due to dramatic
alterations in the polymeric structure, such as degradation
of polymers upon the application of a specific stimulus by
bond breakage in the polymer backbone or at pendant
cross-linking groups [8].
Stimuli-responsive systems containing polymers can be
designed either with a responsive polymer, or by combin-
ing a polymer with a responsive compound, the polymer
serving only as a template/carrier for that compound. Here
we will focus only on the stimuli-responsive systems
involving polymers as smart components, i.e. their prop-
erties and structures are changing in response to a specific
stimulus. In addition, we are interested to mainly present
supramolecular polymers assemblies in solution because
they are extensively used both in therapeutic and in
detection approaches. Note that the huge chemical diver-
sity of polymers proposed for their stimuli-responsiveness
(we will describe in the first part of our review) is dra-
matically reduced when medical applications are intended
due to the biological constraints, we mentioned above. In
this particular field it is extremely important to understand
the parameters and mechanisms related to the distribution
and transport of the nanosystems in the body. Controlling
these parameters is necessary to answer the various con-
cerns that will arise regarding environmental risk and side
effects associated with the use of nanostructures in the
body [9].
In this respect in the last part of the review we will focus
on systems that are already used in medical applications, or
have possible medical applications.
2 Stimuli-Responsive Polymers
The strategy underlying polymer-containing responsive
systems is a dramatic physicochemical change caused by
stimuli. At the macromolecular level, polymer chains can
be altered in different ways, including changes in hydro-
philic-to-hydrophobic balance, conformation, solubility,
degradation, and bond cleavage, and these, in turn, will
cause detectable behavioral changes to self-assembled
structures [10]. Many designs that vary the location of
responsive moieties or functional groups are possible.
Locations include, but are not limited to: side chains on one
of the blocks, chain end-groups, or junctions between
blocks. The response may be reversible or not, depending
on the strategy employed.
Stimuli are commonly classified in three categories:
physical, chemical, or biological (Fig. 1) [11, 12]. Physical
stimuli (light, temperature, ultrasound, magnetic, mechan-
ical, electrical) usually modify chain dynamics, i.e. the
energy level of the polymer/solvent system, while chemical
stimuli (solvent, ionic strength, electrochemical, pH)
modulate molecular interactions, whether between polymer
and solvent molecules, or between polymer chains [13].
Biological stimuli (enzymes, receptors) relate to the actual
functioning of molecules: enzymatic reactions, receptor
recognition of molecules [14]. In addition, there are dual
stimuli-responsive polymers that simultaneously respond to
more than one stimulus.
2.1 Physically Dependent Stimuli
Physically dependent stimuli mainly include: tempera-
ture, electric field, light, ultrasound, magnetic fields and
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mechanical deformation. However, in this review we focus
only on the stimuli-responsiveness of polymer/copolymer
systems, hence, the physical stimuli reported as actively
changing their properties/supramolecular structures are
temperature, light, and electric field. We mention that
magnetic fields and ultrasound have been used only for
compounds that have been entrapped/encapsulated in
polymer assemblies, and therefore we will not include them
here.
2.1.1 Temperature Responsive Polymers
Temperature-responsive polymers have attracted great
attention in bioengineering and biotechnology applications,
because certain diseases manifest temperature changes
[15]. Normally, these copolymers are characterized by a
critical solution temperature around which the hydrophobic
and hydrophilic interactions between the polymeric chains
and the aqueous media abruptly change within a small
temperature range. This induces the disruption of intra- and
intermolecular electrostatic and hydrophobic interactions
and results in chain collapse or expansion (a volume phase
transition). Typically, these polymer solutions possess an
upper critical solution temperature (UCST) above which
one polymer phase exists, and below which a phase sepa-
ration appears. Alternatively, polymer solutions that appear
as monophasic below a specific temperature and biphasic
above it generally possess a so-called lower critical solu-
tion temperature (LCST). Depending on the mechanism
and chemistry of the groups, various temperature-respon-
sive polymers have been reported: poly(N-alkyl substituted
acrylamides), e.g. poly(N-isopropylacrylamide) (PNiPAAm)
[16, 17], poly (N-vinylalkylamides), e.g. poly(N-vinylcap-
rolactam) (PNVC) [18], and copolymers such as poly
(L-lactic acid)-poly(ethylene glycol)-poly(L-lactic acid)
(PLLA-PEG-PLLA) triblock copolymers [19], and poly
(ethylene oxide)-poly(propylene oxide)-poly (ethylene oxide)
(PEO–PPO–PEO) copolymers [20].
2.1.2 Electro-Responsive Polymers
Electrical and electrochemical stimuli are widely used in
research and applications, due to their advantages of pre-
cise control via the magnitude of the current, the duration
of an electrical pulse or the interval between pulses
[21, 22]. Typical electrically responsive polymers are
conducting polymers, as for example polythiophene (PT)
or sulphonated-polystyrene (PSS), which can show swell-
ing, shrinking or bending in response to an external field
[23, 24]. There are different effects upon electrochemical
stimulation: (a) an influx of counter ions and solvent
molecules causes an increase in osmotic pressure in the
polymer, resulting in a volumetric expansion, (b) control of
the loading/adsorption of polyelectrolyte on to oppositely
charged porous materials, (c) formation and swelling of
redox-active polyelectrolyte multilayers. For example,
when an electrochemical stimulus is applied to multilayer
polyacrylamide films, the combined effects of H? ions
migrating to the region of the cathode and the electrostatic
attraction between the anode surface and the negatively
charged acrylic acid groups lead to shrinking of the film on
the anode side [25, 26].
2.1.3 Photo-Responsive Polymers
Because light can be applied instantaneously and under
specific conditions with high accuracy, it renders light-
responsive polymers highly advantageous for applications
[6]. The light can be directly used at the polymer surface or
can be delivered to distant locations using optical fibers.
Ideally, the wavelength of the laser is tuned to the so-called
biologically ‘friendly’ window [27], the near-infrared part
of the spectrum, which is less harmful and has deeper
penetration in tissues than visible light. In this case, the
light is both minimally absorbed by cells/tissue and max-
imally so by the polymers. Most photo-responsive poly-
mers contain light-sensitive chromophores such as
azobenzene groups [28, 29], spiropyran groups [30, 31], or
nitrobenzyl groups [32, 33]. A variety of azobenzene or
spiropyran-containing photo-responsive polymers, as for
example PAA [34, 35], PHPMAm [36, 37], and PNIPAM
[38, 39], have been reported.
2.2 Chemically-Dependent Stimuli
Chemically-dependent stimuli comprise pH, ionic strength,
redox and solvent.
Fig. 1 Classification of stimuli of stimuli-responsive polymers
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2.2.1 pH-Responsive Polymers
pH is an important environmental parameter for biomedical
applications, because pH changes occur in many specific or
pathological compartments. For example, there is an
obvious change in pH along the gastrointestinal tract from
the stomach (pH = 1–3) to the intestine (pH = 5–8),
chronic wounds have pH values between 7.4 and 5.4 [40],
and tumour tissue is acidic extracellularly [41, 42].
Therefore, unlike temperature changes, this property can be
exploited for a direct response at a certain tissue or in a
cellular compartment. The key element for pH responsive
polymers is the presence of ionisable, weak acidic or basic
moieties that attach to a hydrophobic backbone, such as
polyelectrolytes [6, 10, 43]. Upon ionization, the electro-
static repulsions of the generated charges (anions or cat-
ions) cause a dramatic extension of coiled chains. The
ionization of the pendant acidic or basic groups on poly-
electrolytes can be partial, due to the electrostatic effect
from other adjacent ionized groups [44].
Another typical pH responsive polymer exhibits proto-
nation/deprotonation events by distributing the charge over
the ionisable groups of the molecule, such as carboxyl or
amino groups [45]. pH induces a phase transition in pH
responsive polymers very abruptly. Usually, the phase
switches within 0.2–0.3 U of pH [46]. pH responsive
polymers typically include chitosan [47], albumin [48],
gelatin [49], poly(acrylic acid) (PAAc)/chitosan IPN [50],
poly(methacrylic acid-g-ethylene glycol) [P(MAA-g-EG)]
[51, 52], poly(ethylene imine) (PEI) [53], poly(N,N-diak-
ylamino ethylmethacrylates) (PDAAEMA), and poly(lysine)
(PL) [54, 55].
2.2.2 Ion-Responsive Polymers
The responsiveness to ionic strength is a typical property of
polymers containing ionisable groups. These polymer
systems exhibit unusual rheological behaviour as a result of
the attractive Coulombic interactions between oppositely
charged species, which may render the polymer insoluble
in deionized water but soluble in the presence of a critical
concentration of added electrolytes where the attractive
charge/charge interactions are shielded [56–58]. Therefore,
changes in ionic strength cause changes in the length of the
polymer chains, the polymer solubility and the fluorescence
quenching kinetics of chromophores bound to electrolytes
[57, 59, 60].
2.2.3 Redox-Responsive Polymers
Polymers containing labile groups present an beneficial
opportunity to develop redox-responsive biodegradable or
bioerodible systems. Acid labile moieties inside polyan-
hydrides [61, 62], poly(lactic/glycolic acid) (PLGA) [63],
and poly(b-amino esters) (PbAEs) [64] induce redox
responsiveness. Disulfide groups have also been used to
induce redox responsiveness, because they are unstable in a
reducing environment, being cleaved in favour of corre-
sponding thiol groups [65, 66]. Polymers with disulfide
cross-links degrade when exposed to cysteine or glutathi-
one, which are reductive amino-acid based molecules [67].
Another typical redox responsive polymer is poly(NiP-
AAm-co-Ru(bpy)3), which can generate a chemical wave
by the periodic redox change of Ru(bpy)3 into an oxidized
state of lighter colour [68]. This redox reaction alters the
hydrophobic and the hydrophilic properties of the polymer
chains and results in swelling and deswelling of the
polymer.
2.3 Biologically Dependent Stimuli
Biologically dependent stimuli typically involve analytes
and biomacromolecules such as glucose, glutathione,
enzymes, receptors, and over-produced metabolites in
inflammation.
2.3.1 Glucose Responsive Polymers
Precisely engineered glucose sensitive polymers have huge
potential in the quest to generate, for example, self-regu-
lated modes of insulin delivery [11, 69]. For glucose
responsive polymers, glucose oxidase (GOx) is conjugated
to a smart, pH-sensitive polymer. GOx oxidizes glucose to
gluconic acid, which causes a pH change in the environ-
ment [6]. The pH sensitive polymer then exhibits a volume
transition in response to the decreased pH [69]. In this way,
drastic changes in the polymer conformation are regulated
by the body’s glucose level, which, in turn, significantly
affects enzyme activity and substrate access.
2.3.2 Enzyme-Responsive Polymers
In nature, bacteria located mainly in the colon produce
special enzymes, including reductive enzymes (e.g. azo-
reductase) or hydrolytic enzymes (e.g. glycosidases) which
are capable of degrading various types of polysaccharides,
such as pectin, chitosan, amylase/amylopectin, cyclodex-
trin and dextrin [70–72]. In most enzyme-responsive
polymer systems, enzymes are used to destroy the polymer
or its assemblies. The biggest advantage of enzyme-
responsive polymers is that they do not require an external
trigger for their decomposition, exhibit high selectivity,
and work under mild conditions. For example, polymer
systems based on alginate/chitosan or DEXS/chitosan
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microcapsules are responsive to chitosanase [73]. And
azoaromatic bonds are sensitive to azoreductase [74]. In
this respect, they have great potential for in vivo biological
applications. However, the main disadvantage is the diffi-
culty of establishing a precise initial response time.
2.3.3 Inflammation-Responsive Polymers
The inflammatory process is initiated by T- and B-lym-
phocytes, but amplified and perpetuated by polymorpho-
nuclear (PMN) leukocytes and macrophages. Various
chemical mediators in the process, including arachidonic
acid metabolites, proteolytic enzymes and oxygen metab-
olites, can cause tissue damage. For inflammation-respon-
sive systems, the reactive oxygen metabolites (oxygen free
radicals) released by PMNs and macrophages during the
initial phase of inflammation are the stimuli [75]. Such
chemical mediators have been successfully used as stimuli
for responsive drug delivery. For example, in vivo
implantation experiments revealed that hyaluronic acid
(HA) cross-linked with glycidylether can degrade in
response to inflammation [76].
2.4 Dual-Stimuli
For biomedical applications, a step forward is realized if
the smart materials respond simultaneously to more than
one stimulus. Therefore, increasing the efficacy of drug
therapies may require polymeric materials, which are
responsive to several kinds of stimuli. These will support
the diagnosis of patients by monitoring several physio-
logical changes at once. The dual-stimuli responsive
approach is ideally suited for theragnostic (a combination
of diagnostics and therapy) because some functionalities
can provide on-site feedback and diagnostics, while others
could initiate curing and therapy. Availability of various
physical, chemical and biological stimuli is indispensable
for multiple response functions. Therefore, multi-stimuli-
responsive polymers, especially dual temperature- and
pH-responsive systems, are attracting increasing atten-
tion recently for their advantages in biotechnological and
biomedical applications. For example, a dual-stimuli-
responsive delivery system, using both pH and glutathi-
one-responsive polymeric modules, was developed to
therapeutically deliver medicinal molecules [77]. It was
possible to tune the release kinetics by systematically vary-
ing the composition of the pH-sensitive hydrophobic moiety
(butyl acrylate), by modifying the glutathione-responsive
moiety (pyridyl disulfide acrylate), or by modifying both of
them.
Table 1 summarizes stimuli responsive polymers
grouped by stimulus–response, and contain information
about the synthesis method and application.
3 Stimuli Responsive Polymers with Different
Physical Forms
3.1 Dendrimers
Dendrimers are macromolecules characterized by highly
branched structures. Their properties attract attention for
their applicability as delivery vessels, carriers of imaging
agents, and therapeutically active compounds [78–80].
3.1.1 Temperature Responsive Dendrimers
Various examples of temperature responsive dendrimer
systems (with differing architecture and chemical compo-
sition) used to encapsulate and release drugs are described
in literature: star-shaped poly(e-caprolactone)-b-poly(2-
(dimethylamino)ethyl methacrylate) (HPs-Star-PCL-b-
PDMAEMA) [81], core–shell dendritic poly(ether-amide)
(DPEA) modified with carboxyl end-capped linear poly
(N-isopropylacrylamide) (PNIPAAm–COOH) and carboxyl
end-capped methoxy polyethylene glycol (PEG–COOH)
[82]. It was shown that the temperature sensitivity of
dendrimers can depend on their generation and molecular
mass [83]. Dendrimers based on poly(aminoamide) (PA-
MAM) or poly(propyleneimine) (PPI) were obtained by
introducing isobutyramide (IBAM) groups onto the chain
ends and, in the case of PAMAM dendrimers, the ther-
moresponse was further modulated by introducing various
peripheral alkylamide groups [84].
3.1.2 Photo-Responsive Dendrimers
Photo-responsive carbosilane dendrimers containing
4-phenylazobenzonitrile units at each terminal end were
synthesised for potential applications in conversion of
photo-energy into dynamic energy or in drug delivery
systems [85]. The molecular size of a dendrimer with
azobenzene derivatives depends on the photo- and heat-
isomerization abilities of the azobenzene unit. The photo-
response can also be obtained by introducing O-nitrobenzyl
groups to the surface of hyperbranched polyglycerols
(HPGs) for drug release [86]. The presence of a
hexa(ethylene glycol) outer-shell instead of the hexene
increased the stability of the formed host–guest complexes
but resulted in lower guest release. The stability of the
host–guest complexes depended on the counterion of the
guest molecules. This system offers the opportunity to tune
the nanocapsules to control guest binding and release.
3.1.3 pH- and Ion-Responsive Dendrimers
PAMAM (polyamidoamine) and PPI (polypropylene
imine) dendrimers are known to be ion- or pH- responsive
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in an aqueous environment, due to the charge repulsion of
the multiple amine groups [53, 87, 88]. Biocompatible
acetylated poly(amidoamine) (PAMAM) dendrimers were
used for drug delivery, with dexamethasone 21-phosphate
(Dp21) as the model drug [89]. Cationic (non-acetylated)
and acetylated (acetylation is a convenient strategy to
neutralize the peripheral amine group) dendrimers exhib-
ited different pH-dependent micellization, complexation,
Table 1 Summarize on stimuli responsive polymers grouped by stimulus–response, and contain information about the synthesis method and
application






PNiPAAm [15, 16] Living radical polymerization Water soluble polymer sensor, Tissue adhesion
prevention material
PNVC [17] Living radical polymerization Thermosensitive hydrogel at any temperature
PLLA/PEG/PLLA [18] Ring open polymerization Potential anti-cancer drug carrier





PT [23] Electrochemical Synthesis Drug release and cancer chemotherapy







PHPMAm [35, 36] Sensor
PNIPAM [37, 38] Photodegradation material
Chemically dependent stimuli
pH-responsive polymers chitosan [46]
Biosynthesis
Drug release
Albumin [47] Enzyme immobilization
Gelatin [48] Immunoassay
PAAc/chitosan IPN [49] UV irradiation Wound dressing material and drug release
P(MAA-g-EG) [50, 51] Free-radical, solution
photopolymerization
Controlled insulin delivery
PEI [52] Solution polymerization pH-sensitive controlled release systems
PDAAEMA




Polyanhydrides [60, 61] Melt condensation
polymerization
Potential oral drug delivery systems
PLGA [62] Double emulsion solvent
evaporation
Controlled delivery systems
PbAEs [63] Addition solution
polymerization











Carbodiimide chemistry Self-regulated insulin delivery
Enzyme-responsive
polymers
DEXS/chitosan [72] Layer-by-layer assembly Local and sustained drug release
Azoaromatic crosslinked
hydrogel [73]





Suspension solution reaction Implantable drug delivery
Dual-stimuli PLL block PEG–PLL [76] Side chain reaction and
crosslinking
Enhance gene expression
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and encapsulation behaviour. The acetylated dendrimer
encapsulated the Dp21 under acidic conditions (pH = 3.0),
while the cationic dendrimer encapsulated the drug
under both acidic (pH = 3 and pH = 5.0) and neutral
conditions (pH = 7.4). In addition, pH-responsive release
was different for an acetylated- and a non-acetylated den-
dritic matrix. Non-acetylated dendrimers showed a much
slower release rate than acetylated dendrimers under
conditions of lower pH and a much faster release rate
from non-acetylated dendrimer as pH values decreased.
Degradable 1,3,5-triazaadamantane (TAA) dendrimers
were able to be triggered by the addition of HCl
[90]. TAAs units are stable under basic conditions but
hydrolyze rapidly under acidic conditions to yield basic
by-products [tris(amino-methyl)-ethane]. In the polypho-
sphazene-functionalized diaminobutane poly(propylenei-
mine) (DAB-PN) dendrimeric system used for hydrophobic
drug delivery, release was triggered by sodium chlo-
ride ions [91]. Cations such as Na?, K? complexate eth-
yleneoxy moieties on polyphosphazene chains, which
results in the swelling of the polyphosphazene external
groups.
3.1.4 Redox-Responsive Dendrimers
Degradable polylysine dendrimers with multiple spermine
groups on the surface and non-covalently bound DNA were
synthesized via attachment of the spermine by a disulfide
linker [92], which was cleaved by mild reducing agents
such as glutathione (GSH), therefore causing the release of
DNA. Chemically and electrochemically triggered release
of dendrimer end groups was obtained, based on differ-
ent generations of poly(propyleneimine) dendrimers with
redox-labile, trimethyl-locked quinone (TLQ) end groups
[93]. The TLQ units were released by chemical (Na2S2O4)
or electrochemical (electrolytic current) redox reaction.
Redox-triggered release of dendrimer end groups can be
caused by the physiological redox cofactors (e.g., redox
proteins, ascorbic acid, thiols).
3.1.5 Enzyme/Protein-Responsive Dendrimers
An interesting example of an enzyme-responsive dendrimer
was obtained by the synthesis of dendrimers with a hexyl
ester functionality as the hydrophobic part and polyethylene
glycol (PEG) as the hydrophilic part [94]. These dendrimers
disassembled in response to an enzymatic trigger (enzyme-
porcine liver esterase) due to the incorporation of enzyme-
cleavable ester moieties at the hydrophobic part of the
dendrimers. Enzymatic cleavage of the ester groups caused
disintegration of the dendritic structure and release of the
guest molecule (Fig. 2). The rate of guest release system-
atically decreased with an increase in the dendron genera-
tion (higher generation dendrimers are more tightly packed,
which sterically protects them—the ester functionalities are
less accessible for enzymatic degradation). A similar
strategy was used for the preparation of dendritic micellar
containers [95], based on receptor-ligand binding interac-
tions. PEG was chosen as the hydrophilic part and a decyl
chain as the hydrophobic part. In order to disintegrate the
dendritic structure, biotyn was incorporated (via click
chemistry) as a ligand that bonded to a specific protein-
extravidin. The disintegration of the system was caused by
the biotin–extravidin interaction, which dramatically
changed the hydrophilic–lipophilic balance (HLB) of the
dendrimer molecule. The selectivity of this binding and
release is based on molecular recognition.
3.2 Micelles
Block copolymer micelles are generally formed by the
spontaneous self-assembly of amphiphilic copolymer
molecules in an aqueous environment. Usually they are
spherically shaped core–shell structures with sizes varying
in the range of 10–100 nm. The hydrophobic blocks form
the micelle cores, while the hydrophilic blocks form the
micelle corona (shells). Lipophilic drugs can be solubilized
in the hydrophobic micelle cores, significantly increasing
the drug concentration in an aqueous environment.
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3.2.1 Photo-, Thermo- and pH-Responsive Micelles
Copolymerization of a spiropyran-containing methacrylate
(SPMA) with di(ethylene glycol) methyl ether methacry-
late (DEGMMA) resulted in dual-response (photo- and
thermo-responsive) PSPMA–PDEGMMA material, which
formed micelles and reverse micelles in aqueous solution
(Fig. 3) [96]. Upon exposure to UV light, ring-opening
isomerization of spiropyran (non-polar, hydrophobic, and
colourless under visible light irradiation) occurred, result-
ing in the coloured, polar, hydrophilic form. The photo-
switchable PSPMA block and the thermo-responsive
PDEGMMA block, both PSPMA-core and PDEGMMA-
core micelles, were obtained by changing the temperature
(from 15 to 30C) of the solution and by photo irradiation.
These micelles were used for encapsulation and controlled
release and re-encapsulation of the model drug coumarin
102.
Spiropyran-decorated amphiphilic polypeptide-based
block copolymers PLGASP-b-PEO (poly(L-glutamic
acid)-b-polyethylene oxide) that form micelles and
micellar aggregates also showed conformational changes
(from alpha-helix to random coil and vice versa) under
UV and visible light, respectively [97]. Because the light
used was a medically non-invasive, highly penetrating UV
source, these photoresponsive rod-coil block polypeptides
could be applied as viable model systems to study photo-
induced drug release or light-controlled biomedical
applications. Acid labile micelles of a model amphiphilic
block copolymer, poly(hydroxyethyl acrylate)-b-poly
(n-butyl acrylate) (PHEA-b-PBA) with encapsulated
doxorubicin (DOX) demonstrated that hydrolysis of less
than half of the cross-links in the core was sufficient to
release DOX at acidic pH (5.0) faster than at neutral pH
(7.4) [98].
3.2.2 Enzyme-Responsive Micelles
Examples of polymer peptide conjugates, particles of
which disintegrated in response to the proteinase K signal
[99], are the graft-type polymers (NIPAM–PEP and
NIPAM–PEPEP, NIPAM is N-isopropylacrylamide, PEP and
PEPEP are peptide units) containing a substrate peptide of
protein kinase A (PKA) (PKA forms one of the most
important intracellular signals in cellular signal transduc-
tion). The lower critical solution temperature (LCST) of
NIPAM–PEP was raised from 36.7 to 40C in response to
phosphorylation by activated PKA. The NIPAM–PEPEP
containing a different poly(ethylene glycol) unit formed a
polymer micelle-type particle above the LCST. These
particles disassembled and released drug in response to
phosphorylation catalysed by PKA. The micellization of
the complex of the polymer poly(potassium acrylate)
(PPA) and the surfactant cetyltrimethylammonium bromide
(CTAB), using the fluorescent pyrene as a guest molecule,
resulted in an enzyme responsive system [100, 101].
3.3 Vesicles
Polymer vesicles, also called polymersomes, are spherical
shell structures in which an aqueous compartment is
enclosed by a bilayer membrane made of amphiphilic block
copolymers. Their advantages compared to liposomes are:
greater toughness, greater stability, tunable membrane
properties, capacity to transport both hydrophilic and
hydrophobic compounds (genes, proteins, imaging agents,
anticancer and anti-inflammatory drugs and others), making
them good candidates for applications including drug
delivery, nanoreactors and templates for micro- or nano-
structured materials. They can be used as stimuli-responsive
controlled drug release systems [102–104].
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3.3.1 pH-, Ion-Responsive Vesicles
The response of polypeptides to pH and ionic strength was
used to produce pH-and ion-responsive nanoparticles with
controlled sizes and shapes. Amphiphilic poly(butadiene)-b-
poly(c-L-glutamic acid) (PB-b-PGA) diblock copolymer
vesicles underwent reversible coil-helix transition in response
to pH and, as a result, the sizes of the particles changed from
100 to 150 nm [105]. Also, peptide based biocompatible
polybutadiene-b-poly(L-glutamic acid) (PB-b-PGA), poly-
isoprene-b-poly(L-lysine) (PI-b-PLys) and poly(L-glutamic
acid)-b-poly(L-lysine) (PGA-b-PLys) vesicles demonstrated
multi-responsive behaviour [106]. pH-responsive polymer
vesicles obtained by the aqueous self-assembly of carboxy-
terminated hyperbranched polyesters have the advantage of
simple synthesis (a one-step esterification of the commercially
available hydroxy-terminated hyperbranched polyester) and
the possibility of controlling vesicle size (from 200 nm to
10 mm) by pH changes [107].
The potential of a drug to be released as triggered by pH
changes was demonstrated with poly(ethylene oxide)-b-
poly-(glycerolmonomethacrylate) (PEO-b-PG2MA) drug
conjugates [108]. At a pH close to neutral, ester-bond
linkages were stable and vesicular structures were formed.
When pH was lowered to 2.0–3.5, hydrolysis of the ester
bond took place and the drug was released. pH-sensitive
vesicles made of the copolypeptide polyarginine-b-poly-
leucine (PARG-PLE) were obtained based on the presence
of a polyarginine block [109], the properties of which
allowed vesicular self-assembly and intracellular delivery.
ABC triblock copolymers (PEO–PDPA–PDMA) [poly
(ethylene oxide)-poly(2-(diisopropylamino)ethyl methac-
rylate)-poly(2-(dimethylamino)ethylmethacrylate] of vary-
ing block compositions with asymmetric membranes were
used to demonstrate that the surface chemistry of poly-
mersomes plays a crucial role (Fig. 4). PEO and PDMA
blocks were hydrophilic and the pH-sensitive PDPA block
changed from hydrophilic in acidic solution to hydrophobic
Fig. 4 A Effect of solution pH
on the degree of protonation of
the P and M chains. B Three
possible membrane structures
depending on the block
copolymer morphology: 1 AB
diblock copolymers form an
interdigitated membrane with
chemically identical faces; 2
ABC triblock copolymers where
the central hydrophobic ‘B’
block bridges the membrane
with segregated ‘A’ and ‘C’
interfaces; 3 central ‘B’ block of
ABC triblock copolymer forms
a ‘loop’ within the membrane,
with the ‘A’ and ‘C’ chains
forming a non-segregated
membrane. C Effect of varying
the relative volume fractions of
the hydrophilic ‘A’ and ‘C’
blocks on the polymersome
structure [110]
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at pH 7.0. In vitro cell delivery studies suggest that the
vesicles can be either biocompatible or cytotoxic,
depending on whether the PEO or PDMA block is at the
exterior surface [110].
3.3.2 Temperature-Responsive Systems
Thermo-responsive cross-linked polymer vesicles were
formed by self-assembly of the block copolymer poly(2-cin-
namoylethyl methacrylate)-b-poly(N-isopropylacrylamide)
(PCEMA-b-PNIPAM) and following photo-cross-linking
of PCEMA shells, and were used for temperature-(higher
than 32C) triggered release of 4-aminopyridine [111].
Self-assembly of amphiphilic hyperbranched star copoly-
mers with a hydrophobic hyperbranched poly[3-ethyl-3-
(hydroxymethyl)oxetane] (HBPO) core and many hydrophilic
polyethylene oxide (PEO) arms also showed thermo-sensitive
behaviour [112]. The thermo-sensitivity of the vesicles results
from the partial dehydration of the PEO vesicle corona.
Diblock copolymer poly(N-(3-aminopropyl)methacry-
lamidehydrochloride)-b-(N-isopropylacrylamide) (PAMPA-
b-PNIPAM) vesicles showed not only temperature
responsiveness in a narrow range (25–45C), depending on
the length of the building blocks structures of the polymer,
but were also ‘‘locked’’ by ionic cross linking of the
PAMPA block [113]. Vesicles were stable between pH 0
and 11. However, the particle size was shown to vary with
the pH of the solution. At lower pH values, the vesicles
were bigger (310 nm at pH 3.0), and increasing the pH
value of the solution decreased the size of the vesicles (e.g.
220 nm at pH 10.8).
Thermo-responsiveness can also be obtained by using
the synthetic poly(trimethylene carbonate)-b-poly(L-glu-
tamic acid) (PTMC-b-PGA), diblock copolymer [114].
Temperature induced reversible crystallization/melting
of the PTMC-b-PGA vesicles in water depended on the
vesicle size (membrane thickness). The disruption of the
vesicular structure occurred when the temperature was




systems capable of ‘‘schizophrenic’’ (two or more respon-
sive blocks that can form two different structures triggered
by stimuli) aggregation in aqueous solution were controlled
by varying the pH and temperature [115].
3.3.3 Glucose-Responsive Systems
Oxidation-responsive vesicles from amphiphilic block
copolymers based on ethylene glycol and propylene sul-
phide (PPS) exposed to oxidative conditions were desta-
bilized [116]. Thioethers in the hydrophobic PPS blocks
were changed into hydrophilic sulfoxides, influencing the
hydrophilic–lipophilic balance of the amphiphile and
inducing its solubilization. A poly(ethylene glycol)-b-poly
(styrene boronic acid) (PEG-b-PSBA) system with boronic
acid moieties showed both pH and sugar-responsive
behaviour [117]. Disruption of the assemblies occurred
after adding 0.5 M NaOH to the vesicle solution (Fig. 5).
In addition, in the presence of 200 mM D-glucose, vesicles
were also disrupted. The binding of the sugar molecules to
the ionized boronic acid increased solubility of the PSBA
blocks in water. The polymersomes disassembled com-
pletely in the presence of D-fructose (100 mM) in medium
of pH 10.
3.3.4 Glutathione-Responsive Systems
Drug release systems based on reversibly crosslinked
temperature-responsive nano-sized polymersomes of poly
(ethylene oxide)-b-poly(acrylic acid)-b-poly(N-isopropyl-
acrylamide) (PEO–PAA–PNIPAM), were formed in water
(no organic solvents), which is important in the delivery of
biopharmaceutics [118]. The polymersomes showed high
stability in organic solvent, high salt concentrations, and at
different temperatures, but in the presence of 10 mM
dithiothreitol (DTT) the fast release of encapsulated spe-
cies was observed. Polymersomes based on hydrophilic
poly(ethylene glycol) (PEG) and hydrophobic poly(pro-
pylene sulfide) (PPS) connected by a disulfide bridge,
PEG17–SS–PPS30 were disrupted in the presence of cys-
teine, at a concentration corresponding to the intracellular
level [65]. A similar system, also based on PEG–PPS block
copolymers, was reported earlier [119]. This was the first
example of the use of oxidation (in the presence of H2O2)
in order to destabilize PEG–PPS–PEG vesicles and oxidize
Fig. 5 Schematic structure of PEG-b-PSBA block copolymers and
their equilibrium with D-glucose in a basic aqueous environment, and
formation of polymersomes with a permeable membrane induced by
the sugar responsiveness of the block copolymers [117]
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the central-block sulphide moieties to sulphoxides and
finally to sulphones, this oxidation causing an increase in
the hydrophilicity of the initially hydrophobic central
block.
3.3.5 Light-Responsive Systems
Zhao and coworkers [120] reported the formation of vesi-
cles with PAzo-b-P(tBA-AA) copolymers, where PAzo is a
hydrophobic methacrylate-based azobenzene containing
side-chain liquid crystalline polymer, and p(tBA-AA)
stands for the weakly hydrophilic poly-(tert-butyl acry-
late-co-acrylic acid) polymer. Upon UV-irradiation, the
hydrophilicity switch of the PAzo block from hydro-
phobic to hydrophilic causes a change in the hydrophilic/
hydrophobic balance of the copolymer, inducing vesicle
dissociation.
Using the same chromophore, Lin et al. [121]. reported
a novel photoresponsive polymersome, obtained by self-
assembly of a copolymer composed of hydrophilic poly
(ethylene oxide) (PEO) and hydrophobic azopyridine
containing poly(methacrylate) (PAP). Upon UV-exposure,
several morphology changes were observed, and were
described as a cycle including transitions from initial vesi-
cles to larger vesicles via fusion, disintegration and rear-
rangements. These transitions resulted from the deformation
of the membrane structure due to the isomerization of azo-
pyridine moieties disturbing the tight packing of the polymer
chains in the membrane.
Recently, Mabrouk et al. [122]. reported on a very ori-
ginal light-responsive system. They fabricated polymeric
vesicles in the micrometer-size range, with asymmetric
membranes composed of inert poly(ethylene glycol)-
b-polybutadiene (PEG-b-PBD), and a liquid crystal-
based copolymer, PEG-b-PMAazo444 (PAzo). Upon self
assembly, the PEG–PBD copolymers are segregated in the
inner leaflet of the membrane, while the PAzo copolymers
compose the outer leaflet of the membrane, hence forming
an asymmetric membrane. When the azo moieties are in
the trans form, the PAzo polymer adopts a rod-like struc-
ture in the membrane. When light is switched on, azo
moieties are in the cis form, and the PAzo polymers
undergo a conformational change to reach a coil confor-
mation. Subsequently, the volume occupied by the PAzo
chains increased, leading to a spontaneous change in
curvature and to bursting of the giant vesicles by ‘‘curling’’
of the membrane.
3.4 Smart Surfaces: Surface-Supported Polymer
Layers and Films
In all nanomedicine studies, a major challenge is deter-
mining how nanomaterials will interact with mucosa,
tissues, and targeted cells. New modulation systems that
control the surface properties or solubility of materials in
response to an external signal are designed using the
stimuli-responsive polymers on a material surface, or by
modifying the surface with bioactive substances, such as
enzymes. Indeed, smart surfaces that respond to specific
chemical and biological species have been the basis for the
fabrication of highly sensitive, reagent-less, re-usable bio-
sensors [22].
Surface grafted polymers can be defined as long chain
polymer molecules that are attached to a surface through
one or a few anchor sites [123]. Two primary covalent
attachment techniques, i.e. ‘‘grafting-to’’ and ‘‘grafting-
from’’, have been reported to create polymer brushes. In
the ‘‘grafting-to’’ technique, a pre-formed end-functional-
ised polymer in a solution reacts with a suitable substrate
surface to form a tethered polymer brush. In the ‘‘grafting-
from’’ method, also called the surface-initiated polymerization
method, monomers are polymerised from surface-anchored
initiators generally immobilised by the self-assembled
monolayer technique (SAM) [124, 125]. SAMs offer ease of
preparation and versatile surface chemistry, while polymer
brushes can be produced by surface-initiated polymerization
techniques with improved control of surface coverage, thick-
ness and composition.
Stimuli-responsive polymer films can be prepared on
substrate surfaces using several deposition techniques of
differing complexities and applicability, such as spin
coating, chemical vapour deposition, laser ablation, plasma
deposition, and chemical or electrochemical reactions
[126–128]. The choice of deposition methods depends on
the physicochemical properties of the polymer material, the
film quality requirements and the substrate being coated.
3.4.1 Temperature-Responsive Surfaces
The most widely studied temperature-controlled films are
built from PNiPAAm, a thermo-responsive polymer that
has an LCST of 32C in aqueous solution [129]. PNiPAAm
chains present a widespread hydrogen bonding network
between the amide groups and water molecules. Above
LCST, PNiPAAm films undergo a phase transition, from a
hydrated swollen state to yield a collapsed morphology
(solvent is forced out) [130–132]. The reversible volume
phase transition of PNiPAAm films can be utilised to
develop thermo-responsive culture media for cells [133–
135].
Surface attached stimuli-responsive polymers do not
aggregate to form a separate phase, but the conformational
transition from the hydrophilic to hydrophobic state
endows the surface with regulated hydrophobicity. For
example, when PNiPAAm was end-grafted to solid sub-
strates, it provided the surface with thermally controlled
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wettability and thickness [136]. At low temperatures, the
composition profiles are approximately parabolic and
extend into the solvent, while at temperatures above the
LCST, the polymer profiles are collapsed near the surface.
Moreover, nano-patterned thermo-responsive poly(2-(2-
methosyethosy)-ethyl methacrylate) brushes demonstrate
switching of both the thickness and the topography under
temperature stimuli [137].
3.4.2 Electro-Responsive Surfaces
Height changes of polyelectrolyte brushes in response to
the presence of ions of different sizes and charge were
recently actively explored. When polymer chains bond
with counter ions, the swelling and the hydrophilic/
hydrophobic properties of the polymer layer change, while
patterned brushes with two oppositely charged polyelec-
trolytes provide reversible switching of wettability,
charge, and topography in an inverse manner. For exam-
ple, by employing the electrochemical reaction in which
aromatic nitro (NO2) groups can be chemically modified
by a redox process to amino (NH2) groups, a surface can
be functionalized by site-selective and reaction-controlled
immobilisation of DNA [138, 139], and protein [140].
Also, by using the electroactive O-silyl hydroquinone
moiety to tether the RGD peptide ligand to the monolayer,
electroactive functionalised surfaces based on the hydro-
quinone–quinone redox couple have been shown to allow
real-time control of molecular interactions that mediate
peptide attachment and consequently the adhesion of cells
[141].
On the basis of reversible doping of conducting poly-
mers, a variety of anions have been electrostatically
entrapped in conducting polymer films and released by
electrical stimulus in a controlled way. As an example of
this, positive charged neurotransmitter dopamine was
successfully released from a conducting composite poly-
mer, poly(N-methyl pyrrolylium)/poly(styrene sulfonate),
prepared by anodic polymerization [142]. In its reduced
state, this film was able to bind dopamine cations, which
were then released by oxidizing the polymer film. Another
example is polypyrrole films that can reversibly change
their oxidation state, and consequently their properties and
surface binding characteristics [143].
3.4.3 Photo-Responsive Surfaces
As described previously, there are mainly two types of
photo-responsive molecules that may be used for a photo-
triggered response. Spiropyran derivatives can transform
from a hydrophobic spiro conformation to a polar hydro-
philic zwitterionic merocyanine conformation under UV
light, and can reversibly change with visible light [144,
145]. This change from the hydrophobic to the hydrophilic
state upon isomerisation has been applied to demonstrate
UV light-induced modification of surfaces [145]. The
second type is azobenzene molecules that can change from
the stable trans form to the cis state under UV light irra-
diation (300–400 nm), and reverse the isomerisation by
irradiation with visible light [146–148].
A photo-responsive copolymer monolayer combining
PNiPAAm and spiropyran chromophores has been used to
tailor cell-adhesion by switching light on or off [149].
Change in surface hydrophilicity was obtained by irradia-
tion with 365 nm light and ‘reset’ by visible light irradia-
tion (400–440 nm) [144]. Additionally, a surface that can
be photo-activated for spatio-temporal control of cell
adhesion has also been developed by the release of nitric
oxide from 2-nitrobenzyl ester-terminated monolayer [150,
151]. The 2-nitrobenzyl groups were selectively removed
and consequently the protein and polymer dissociated from
the surface.
3.4.4 pH-Responsive Surfaces
Polyelectrolyte brushes are pH-responsive materials that
undergo structural changes at interfaces when their chains
are charged and/or discharged because of the protonation/
dissociation of acid/base groups [152]. As a result, upon an
alteration in pH, polyelectrolyte brushes transform from the
swollen state to a shrunken state in which the polymer
chains collapse [153]. For example, surfaces grafted with
an Os-complex redox unit modified poly(4-vinyl pyridine)
[154]. Another type of surface was obtained from a mixed
polyelectrolyte brush consisting of poly(2-vinylpyridine)
and poly(acrylic acid) that had switchable permeability for
both anions and cations [155]. When the ambient pH was
acidic (pH \ 3), the poly(2-vinylpyridine) chains were
positively charged and permeable to the anionic probe.
However, the redox process for the cationic probe was
prevented, resulting in a lack of transport for positively
charged ions.
3.4.5 Dual-Stimuli Responsive Surfaces
A smart and stable polymer brush interface based on
PNiPAAm, PAA and poly(N-isopropylacrylamide-co-
acrylic acid) was able to reversibly respond to temperature,
ionic strength and pH, independently or simultaneously
[156]. The reversible change in hydrogen bonding between
the two components (NIPAm and AAc) and water, and the
ionization of carboxylate groups under different environ-
mental condition resulted in the dual-stimuli response.
Chitosan based PNiPAAm films possessing both thermal
and pH sensitivity were prepared by blending chitosan with
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PNiPAAm and PEG [157]. The resulting film had an LCST
at around 32C, due to PNiPAAm, and showed pH
responsiveness due to the amino groups of chitosan com-
ponent. Poly(vinylidene fluoride) (PVDF) hydrophobic
films grafted with PAA via radiation grafting demonstrated
convective permeability that changed significantly with the
pH and/or the salt concentration of the surrounding fluids
[158].
3.5 Polymer–Protein and Polymer–Drug Conjugates
Polymers conjugated with therapeutic agents have been
extensively investigated over the past 30 years. Conjuga-
tion of polymers to therapeutic molecules resulted in
macromolecular systems that synergistically combined the
individual properties of the components. Drug solubiliza-
tion, protein efficacy and stability are increased by conju-
gation, while immunogenicity and toxicity are lowered.
3.5.1 Temperature-Responsive Conjugates
Azido-terminated poly(N-isopropylacrylamide) (PNiPAAm–
N3) was conjugated to bovine serum albumin (BSA) [159].
When the temperature increased above the PNiPAAm lower
critical solution temperature (LCST), the PNiPAAm–BSA
bioconjugates formed stable nanoparticles composed of
dehydrated polymer and hydrophilic protein. As an alterna-
tive to this systems, protein–polymer conjugates are based on
biocompatible polyethyleneglycol methacrylate (PEGMA)
[160]. Hybrid polymer–protein (PEGMA–trypsin) conjugates
are promising candidates for biomedical applications. The
first hybrid (diblock conjugate) and the second hybrid
(triblock) demonstrated behaviour depending on their archi-
tectures but also their enzymatic activities—hydrolysis of
peptide and protein substrates were different for various
hybrids. This is an example of polymer–protein conjugates
with varied architectures, and it can be used to regulate the
properties of the protein polymer hybrids in terms of stability
and reactivity.
3.5.2 pH-Responsive Conjugates
A pH-sensitive polymeric carrier for drug release in cancer
therapy made of poly(vinylpyrrolidone-co- dimethylmaleic
anhydride) (PVD) was conjugated with the drug adriamy-
cin (ADR) [161]. At pH 8.5 no release of the drug from the
conjugate was observed. In contrast, at neutral pH (7.0) and
slightly acidic pH (6.0), fully active drug in the native form
was released.
Also, anticancer polymer [P(N-(2-hydroxypropyl)meth-
acrylamide)] drug conjugates, containing doxorubicin
(DOX) attached via a pH-responsive hydrolytically labile
spacer susceptible to hydrolysis (hydrazone conjugates)
showed stability in pH 7.4 buffer but released DOX in
response to pH change (from 7.4 to 5.6) [162].
3.5.3 Glutathione-responsive conjugates
N-acetyl-L-cysteine (NAC) is an antioxidant and anti-
inflammatory agent with significant potential for applica-
tions in the treatment of stroke, neuro-inflammation and
cerebral palsy. However, NACs with free sulfhydryl groups
display high plasma binding, resulting in low stability and
reduced drug efficacy. Conjugates of NAC with thiol-ter-
minated multiarm (6 and 8) poly(ethylene–glycol) (PEG)
with disulfide linkages involving sulfhydryls of NAC
released the drug at intracellular GSH levels [163]. At
physiological extracellular glutathione concentration
(2 lM), both conjugates were stable and release of the
NAC was not observed. NAC was also conjugated to
poly(amidoamine) (PAMAM) dendrimers [164, 165]. PA-
MAM dendrimers, G4–NH2 and G3.5–COOH, all with
cleavable disulfide linkages, were designed for intracellular
delivery. Based on PEG, a dendritic system for intracellular
peptide delivery was manufactured via cleavable disulfide
bonds [166]. The variable quantity of the disulphide linker
allowed the adjustment of the cleavage and release of the
drug peptide. Disulphide bonds were also used for the
preparation of triazine dendrimer-paclitaxel (PAX) conju-
gates, as was an ester bond [167]. N-(2-hydroxypro-
pyl)methacrylamide (HPMA) copolymer and TNP-470
([O-(chloracetyl-carbomoyl) fumagillol]), an angiogenesis
inhibitor, were covalently bound to GFLG (Gly-Phe-Leu-
Gly) linker via an enzymatically degradable bond, ethy-
lenediamine [168]. When the concentration of lysosomal
cysteine proteases such as cathepsin B increased (this
happens in many tumour endothelial cells), cleavage of the
linker took place. This conjugate was studied further in
vivo and in vitro and went to preclinical trials under the
name caplostatin [169, 170].
3.5.4 Dual-Response Conjugates
Dual-response conjugates are also known. A biotin-termi-
nated poly(N-isopropylacrylamide)-b-poly(acrylic acid)
(PNiPAAm)-b-(PAA) was conjugated to streptavidin (SA)
via the terminal biotin on the PNiPAAm block [171].
Interestingly, the usual aggregation and phase separation of
PNiPAAm-SA following the thermally triggered collapse
and dehydration of PNIPAAM (the lower critical solution
temperature of PNiPAAm is 32C in water) was prevented
by the shielding of the PAA block. In addition, the
aggregation properties of the [(PNiPAAm)-b-(PAA)]-SA
conjugate were pH dependent. By varying temperature
and pH, the sizes of these particles differed from 60 nm
(pH 7.0, temperatures above the lower critical solution
Biointerphases (2012) 7:9 Page 13 of 27
123
temperature of PNiPAAm) to 218 nm (pH 5.5 and 20C).
This was explained by hydrogen bonding between the
–COOH groups of PAA with other –COOH groups and
also with the –CONH– groups of PNIPAAM. The aggre-
gation properties of the block copolymer–streptavidin
conjugate differ from those of the free block copolymer.
4 Applications of Stimuli-Responsive Polymers
in Nanomedicine
The need for accurate and non-invasive diagnostic tools is
essential for early intervention to prevent disease progres-
sion. In this regard, the development of nanodevices
capable of detecting specific and meaningful analytes
associated with syndromes, of visualizing the location and
distribution of affected cells, and of reporting the activity
of a therapeutic agent are highly desirable.
In therapy, the introduction of these agents into the body
(regardless of the administration route employed) is con-
fronted by a set of efficient biological barriers, constituting
the body’s system defenses. Building smart nanoscale
systems that are able to circumvent such barriers is seen as
a potential way to administer therapeutic agents in a safe,
selective, and efficient manner.
As described previously, polymeric systems are avail-
able in a variety of forms and structures, from bulk to
supramolecular assemblies. In addition, because of their
unique properties, stimuli-responsive polymers offer many
opportunities to introduce functionalities into nanostruc-
tures and allow the fabrication of various smart systems.
The exploitation of polymer responses to stimuli finds
wide-ranging application in the biomedical field: smart
systems are useful in imaging and sensing (diagnosis),
controlled drug delivery and regenerative medicine (ther-
apy), but also in bioseparation, gating valves, or transport
and microfluidics [22, 104, 172–180].
In the next sections, we will highlight the most relevant
applications of such polymers in several subfields of
nanomedicine, and pay particular attention to the advan-
tages and drawbacks associated with those techniques. We
focus on systems exploiting the intrinsic properties of
stimuli-responsive polymers, i.e. where the functioning of
nanostructures is a direct result of polymer chain properties
that change upon activation by a given stimulus. Therefore,
stimuli such as a magnetic field and ultrasound fall beyond
the scope of this review, because they are applied to
nanoparticles found within a self-assembled system.
4.1 Diagnosis
Polymer sensors that respond to relevant biomolecules and
analytes, as well as pH and temperature, may be very
useful in the detection of diseases that are usually accom-
panied by a significant imbalance in chemicals or varia-
tions of physical variables in the environment. Because
monitoring these changes and gradients is vital to the
diagnosis of certain diseases, great efforts have been made
in the field of polymeric biosensors. Another important
feature of nanodevices used in biomedical applications is
their ability to self-report effective functioning (delivery in
a specific location for instance) with the use of imaging
techniques.
4.1.1 Sensors
In the field of polymer sensors, the most relevant examples
in literature make use of smart surfaces (either composed
of self-assembled multilayers or thin polymer films)
responding to a change in the conformation of polymer
chains, smart polymer probes that respond to chemical
modification of polymer chains, and self-immolative den-
drimers [181]. In the next sections, these systems are
reviewed and classified according to their specific
applications.
4.1.1.1 Systems for the Detection of Physical Variables
(pH and T) Several groups exploited the motion of par-
ticles, such as gold nanoparticles or quantum dots linked to
responsive polymer brushes anchored to a surface, in order
to design polymeric nanosensors [182–184]. In such devi-
ces, conformational changes of the polymer chains caused
by a given stimulus induce a vertical motion to the nano-
particles which can be easily monitored using surface
plasmon resonance spectroscopy (SPR). In one example of
a pH nanosensor, poly(2-vinylpyridine) (P2VP) polymer
brushes reversibly collapsed due to a pH switch from 2 to 5
[183]. Surfaces acting as nano-thermometers were devel-
oped using a similar approach with core/shell CdSe/ZnS
quantum dots attached to PNiPAAm polymer brushes [185].
Another type of sensor, known as a fluorescent poly-
meric sensor, presents the advantage of being based solely
on the intrinsic properties of polymers. In these systems, a
combination of stimuli-sensitive monomers and polymer-
izable fluorescent dyes compose the segments of the
copolymers. Because the dye fluorescence is strongly
dependent on its environment, significant changes in the
fluorescence signal are observed upon changes in polymer
chain hydrophilicity induced by stimuli. Such a copolymer
of PNiPAAm and benzofurazan dye-modified units was
reported by Uchiyama et al. [186], and showed a clear and
reversible response to temperature cycles, associated with
PNiPAAm chain conformational changes and the polarity
sensitivity of the benzofurazan moieties (Fig. 6A). The
same group reported other polymers based on the same
concept using a variety of dyes [187]. It should be
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mentioned that, in these systems, the temperature is cor-
related to the fluorescence intensity variations, which may
be influenced by local concentration gradients, and that
difficulties associated with measurement may occur (signal
to noise ratio).
To address this drawback, devices from which the
temperature (or other stimuli like pH) may be correlated to
emissions at different wavelengths were proposed. In this
regard, we describe here some examples using the fluo-
rescence resonance energy transfer technique (FRET).
The transition from coil to globular conformation of
responsive polymers was used in combination with FRET
to produce pH and temperature sensors. As an example, a
diblock copolymer of poly(ethylene glycol) and poly
(sulfadimethoxine) (PEG–PSDM) was synthesized, with a
FRET donor as a linker between the two chains, and a
FRET acceptor as an end-group on the PSDM chain. When
pH switches from 7.6 to 6.8 (values framing SDM pKa),
the pH-responsive PSDM chains switch from coil to
globular conformation. Consequently, the distance between
Fig. 6 A Fluorescent polymer sensor for temperature [186]. B Fluo-
rescent polymer sensor for the detection of fluoride ions [194].
C Micrograph showing the microfluidic hot plate with gold hot lines
and fluorescence microscopy images showing thermally triggered
release of fluorescein-labeled myoglobin from the PNiPAAm surfaces
[192]
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the FRET molecules varies as a function of pH, and the
emission wavelength changes accordingly [188].
In recent work, Wu et al. [189] reported the fabrication
of silica nanoparticles coated with PNiPAAm temperature-




were copolymerized with NiPAAm to yield P(NiPAAm-
co-NBDAE)-b-P(NiPAAm-co-SPMA) copolymer brushes.
According to the temperature variations that induce
PNiPAAm collapse, specific emissions from FRET moie-
ties were observed.
These two systems represent good examples of fluo-
rescent pH- and thermo-meters.
4.1.1.2 Systems for the Detection of Small Analytes and
Biomolecules Detectors based on SPR spectroscopy have
also been used successfully for immunoassay devices based
on the enzyme-catalyzed degradation of polymer films.
Sumner et al. coated substrates with poly(ester amide) films
sensitive to chymotrypsin, and poly(trimethylene) succi-
nate films sensitive to lipase. The decrease in polymer film
thickness resulting from the gradual degradation of the
polymer chains activated by the enzymes and monitored
with SPR was shown to be directly proportional to the
enzyme concentration. Therefore, the sensor was proposed
as a simplified alternative to ELISA tests [190].
Another array nanodevice based on a microfluidic hot
plate grafted with PNiPAAm polymer was reported [191].
It was shown that, depending on the temperature of the hot
line, the surface adsorbed and desorbed proteins within
seconds (Fig. 6C) [192]. As competitive adsorption/
desorption between two proteins occurs interdependent
with heating time, the system can be used for selective
analysis and separation of proteins.
Another type of detection based on the sensing of ana-
lytes via specific chemical reactions changing the proper-
ties of polymers has also been reported. An example of
fluorescent amplification via enzymatic degradation of a
polymer chain was reported recently by Tanaka et al. [193].
A polymer with a phosphate-caged fluorescein main chain
was synthesized via polycondensation with diol linkers.
Although the polymer obtained was not fluorescent,
digestion of the backbone with alkaline phosphatase
released highly fluorescent moieties, and the polymer was
used to assess the enzymatic activity of a cell lysate.
Chemically induced response was also proposed by
several groups to detect potentially toxic elements in
drinking water. Although this application may not be core
nanomedicine, we mention it in this review because it
represents an improvement to prevent future complications
and diseases. Kim et al. [194] synthesized a polymer with
coumarin derivatives as side groups, able to detect fluoride
ions (F-). The structure of coumarin derivatives can be
converted back to coumarin by fluoride ions, thus restoring
their fluorescent properties (Fig. 6B). This represents a
good example of a fluorescent polymeric sensor for F-.
The detection of highly toxic mercury using fluorescent
polymers was also reported, using a copolymer of poly
(ethylene oxide)-b-poly(N-isopropylacrylamide-co-RhBHA)
[PEO-b-P(NiPAAm-co-RhBHA)], where RhBHA is a rho-
damine-based Hg2?-sensitive dye [195]. Detection is based
on the selective ring-opening of the RhBHA moieties by
Hg2? to yield fluorescent acyclic moieties. In this account,
authors also investigated the effect of the thermo-induced
self-assembly of the amphiphilic block copolymer on the
fluorescence intensity and found that, upon formation of
micelles, the fluorescent moieties were located inside the
hydrophobic core, significantly enhancing the fluorescence.
Many other systems exist for the detection of different ana-
lytes, such as metalloproteins and transition metals [196, 197].
The group of Sun developed several sensors based on
wettability switching (i.e. a reversible transition from
superhydrophilicity to superhydrophobicity) of surfaces
grafted with PNiPAAm [178]. They synthesized block
copolymers comprising PNiPAAm segments and blocks
able to recognize different biomolecules. For instance,
poly(N-isopropylacrylamide)-poly(phenyl boronic acid)
(PNiPAAm-PBA) surfaces exhibiting a dramatic change in
the presence of glucose, or PNiPAAm comprising oligo-
peptide units able to bind specific saccharide enantiomers
based on chiral recognition, have been reported and used to
monitor activity and concentration levels.
A novel class of recently developed molecules called
self-immolative dendrimers showed promising use in dif-
ferent applications, including diagnostics and drug deliv-
ery. The self-immolative dendrimer molecules comprise a
triggerable focal point, which initiates a cascade-like
fragmentation of the structure into its building blocks upon
activation. It is possible to design the building blocks as
active molecules that can be detected once cleaved (these
molecules being known as reporters). The release of these
subunits can be seen as an amplification of the activation
signal (physical, chemical or biological).
Using this approach, Danieli et al. [198] built dendrons
with a phenylacetamide group as a point of focus, and two
different probes as reporters. As the phenylacetamide
group is a substrate of bacterial enzyme penicillin-G-ami-
dase (PGA), the dendrimers readily degraded upon enzy-
matic activation, and subsequent detection of the two
reporters allowed the evaluation of enzymatic activity.
Because of the limitations of dendrimers, especially the
limited number of building blocks due to steric hindrance,
the concept was adapted to linear polymers, coined self-
immolative polymers [199], to improve the amplification of
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the signal. One drawback of these self-immolative systems
is that the chemistry used in the cascade-like degradation
has been, until now, exclusively based on aromatic com-
pounds and the toxicity of such cleaved compounds rep-
resents a potential issue in terms of biocompatibility [200].
4.1.2 Imaging
It is interesting to note that the concept of fluorescent
polymeric sensors presented previously may be used
reversibly, as an imaging technique for the detection of
diseased tissues that show slightly elevated temperatures or
acidic pH. A good example was reported using polymers
comprising dyes sensitive to near infrared (NIR), which is
the ideal wavelength range for biomedical applications,
since it has superior depth penetration in tissue as opposed
to other wavelengths. In this work, Lee et al. [201] made
use of Pluronic triblock copolymers [poly(ethylene oxide)-
poly(propylene oxide)-poly(ethylene oxide) (PEO–PPO–
PEO)] end-capped with a cyanine dye (Cy5.5). Contrary to
PNiPAAm polymers showing an intrinsic responsive
property, Pluronic block copolymers react to temperature
via changes in their supramolecular interactions. Upon
heating, the polymer chains evolve from a dissolved state
to a micellar aggregation state. According to this work, the
transition from dissolved chains to micelles is accompanied
by fluorescence quenching of the Cy5.5 terminal dye. In
turn, these structures can be used as NIR thermo-probes for
imaging.
Another imaging system using stimuli-responsive den-
drimers was developed by Criscione et al. [202]. They
synthesized PAMAM dendrimers with fluorinated end
groups that self-assembled into nano- and micro-particles.
The system can deliver drugs under pH-induced disas-
sembly, and the fluorine spins can be used for in vivo
imaging using 19F magnetic resonance imaging (19F MRI).
Experiments with mice show that the dendrimers can be
tracked with non-invasive imaging (Fig. 7A). Interestingly,
a shift in relaxation time was observed according to
changes in environmental pH, meaning that the system can
also be used as a powerful imaging technique for the
localization of tumor, with acidic pH.
The detection of hydrogen peroxide is very desirable, as
it is over-produced in a number of diseases. A smart system
capable of imaging H2O2 in vivo was proposed by Lee
et al. [203]. The nanoparticles were built from peroxalate
polymers embedding a fluorescent dye, pentacene. The
polymers reacted with hydrogen peroxide to form
Fig. 7 A Self-assembly of fluorinated PAMAM dendrimers with
fluorine groups for 19F MRI imaging. 1H and 19F images showing
accumulation in vivo after IV injection of the nanoparticles: Overlaid
picture of showing localization of the particles in the renal vasculature
and localization of the particles in the liver after efficient filtration.
[202] B Peroxalate–pentacene nanoparticles and H2O2-induced reac-
tion yielding fluorescence, and in vivo imaging of hydrogen peroxide
production in the inflamed peritoneal cavities of mice [203]
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dixioetanedione intermediates that, in turn, excited the
fluorescent dye, leading to light emission in the
460–630 nm wavelength region. Imaging efficiency was
investigated in vivo with mice injected with lipopolysac-
charide, inducing an inflammatory response. As shown in
Fig. 7B, the nanoparticles were capable of imaging H2O2
production in the peritoneal cavity of mice.
4.2 Therapy
In this section, the use of stimuli-responsive polymers is
classified into two categories. The first deals with devices
used as nanocarriers for the transport and delivery of
therapeutic agents. As mentioned earlier, the delivery of
compounds to a specific location of the body is subject to a
variety of obstacles, known as biological barriers, includ-
ing the reticulo-endothelial system, endothelial/epithelial
membranes, complex networks of blood vessels, abnormal
flow of blood, and interstitial pressure gradients and the
blood–brain barrier [9]. According to the nature of the
therapeutic agent, these barriers may simply reduce the
efficacy of the treatment, or completely prevent or anni-
hilate its effect. Therefore, one can easily understand the
benefit of using a protective vehicle to avoid early
screening or biodegradation of a given cargo, with the goal
of improving pharmacodynamics and pharmacokinetics,
and delivering an intact molecule to a specific target in a
controlled manner.
In the second section, we present some interesting works
dealing with the use of stimuli-responsive polymers in the
field of regenerative medicine. Synthetic polymers have
been used to produce scaffolds and supports for cell
growth, and the functionalities offered by stimuli-respon-
sive polymers have actually improved those systems a
great deal in the direction of biomimetic materials.
4.2.1 Delivery Systems
Delivery applications of smart polymers constitute an
overwhelming collection of articles, referring to virtually
all polymeric nanostructures described previously. The
most trivial structures used for the entrapment and sub-
sequent release of small hydrophobic molecules are
micelles. However, the use of classic micellar structures is
limited to the encapsulation of hydrophobic drugs in the
core, at a time when the demand for carriers able to
encapsulate hydrophilic compounds is ever growing.
Polymeric vesicles, or polymersomes, have the advantage
of encapsulating hydrophobic and hydrophilic therapeutic
agents. As reported by Onaca et al. [176], they find
applications as nanocarriers for hydrophilic and hydro-
phobic low molecular weight drugs, proteins, enzymes, and
genes. A number of other polymeric nanostructures have
shown great potential in drug delivery, including dendri-
mers, smart surfaces, and in situ forming nanogels, and will
be briefly addressed in this review.
Due to the length of the present review, we focused on
the most relevant works, with very promising or demon-
strated applications in nanomedicine. The examples
described below pertain to the triggered delivery of low
molecular weight drugs, proteins and enzymes, as well as
genes. The stimulus used may be external (i.e. external
application of localized light irradiation, ultrasound, or
temperature) or internal (i.e. the system responds to local
hyperthermia, elevated pH, or over-expression of proteins
and enzymes in a tumor environment) [204].
4.2.1.1 Delivery of Low Molecular Weight Drugs Most
of the low molecular weight drugs are hydrophobic mole-
cules, and as such may be limited in their use due to sol-
ubility issues. Therefore, their pharmacodynamics and
pharmacokinetics are greatly enhanced by solubilization in
the hydrophobic domains of micelle cores, or dendrimers,
or even the membranes of polymersomes, or by conjuga-
tion to polymers. Their release in the body can then be
mediated by a number of different stimuli.
Doxorubicin (DOX), an anticancer hydrophobic drug, is
perhaps most studied. However, many other small drugs have
been used, including paclitaxel (PAX), camptothecin, cispl-
atine, dexamethasone, indomethacin, N-acetyl cysteine, …
As discussed previously, a number of systems exploit
the pH differences found in the body, whether in the
vicinity of a tumor, or in endosomes. In those systems, the
pH effect may result in the cleavage of pH-sensitive bonds
(hydrozone, acetal), as was shown with drug–polymer
conjugates releasing doxorubicin, paclitaxel, indomethacin,
and camptothecin, which were covalently attached to
polymer blocks forming micelles via acid-labile linkages
[108, 205–208]. As an example, polymer–DOX conjugates
were designed with hydrazone or amide pH-sensitive bonds
linking the drug to a poly(ethylene glycol)-poly(caprolac-
tone) (PEG–PCL) diblock copolymer [208]. The pH-trig-
gered release and cellular uptake were evaluated in vitro
with MDA-435/LCC6WT and MDA-435/LCC6MDR cells.
The therapeutic effect was also investigated in vivo on
mice bearing tumors, and tumor regression was shown to
be more significant for mice treated with the polymer–
DOX micelles (Fig. 8A).
The liberation of DOX was also shown using a dendritic
polyester with pH-sensitive linkers [209]. Dendrimers as
drug delivery systems have advantages over classic poly-
mers, due to their well-defined architecture (low polydis-
persity, specific morphology, high density of functional
groups) [210]. Drugs can be entrapped in dendrimer struc-
tures via encapsulation, complexation through electrostatic
interactions, or covalent attachment (conjugation) [210].
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Drug–polymer conjugates are more attractive than drug–
dendrimer complexes, because of their increased stability
and higher payloads.
As reported by Ahmed et al., polymersomes have also
been used as nanocarriers for smaller drugs. They reported
on polymer vesicles capable of encapsulating a cocktail of
anticancer drugs, PAX (hydrophobic, entrapped in the
membrane) and DOX (DOX–HCl salt, hydrophilic, encap-
sulated in the inner pool) [211]. The contents can be released
from polymersomes via poration in the membrane induced
by pH-triggered degradation of the PLA blocks. The system
was tested in vivo, and tumors in rats were shown to shrink
significantly (by 50% in 5 days). The limitation of the sys-
tem, and of biodegradable polyesters in general, is due to the
rather slow rate of poly(lactic acid) hydrolysis.
The reducing intracellular environment, due to the
presence of glutathione, or the action of enzymes (including
NADH-oxidase and disulfide isomerase) was also used to
trigger the release of smaller drugs via cleavage of reduc-
tion-sensitive linkages. As an example N-acetyl cysteine
(anti-inflammatory agent) was conjugated to polyamido-
amine (PAMAM) dendrimers via disulfide linkages, and
released in the intracellular domain, in the presence of
reducing agents (glutathione, cysteine) [164]. The efficacy
of the system was assessed by measuring the reactive
oxygen species level in microglial cells. After 72 h, up to a
125% reduction of H2O2 was observed for cells treated with
the loaded dendrimers. The efficacy of micelles sensitive to
a reducing environment was also demonstrated, with a
system based on camptothecin–polymer conjugates [212].
Responsiveness to temperature was exploited as well.
Most of the temperature-sensitive systems are based on
PNiPAAm. Using a thermo-responsive block copolymer,
PEO- PNiPAAm, Qin et al. [213]. prepared vesicles which
can encapsulate doxorubicin, and sequester a hydrophobic
dye in their membranes. Upon cooling to temperatures
below PNiPAAm LCST, the membrane is dissolved, and
both contents are released upon complete dissociation of
the vesicles. Quan et al. [214] designed thermo-respon-
sive micelles from a poly(N-acroyloxysuccinimide)-b-poly
Fig. 8 A Mitochondrial, endosomal and nuclear distribution of DOX
in MDA-435/LCC6WT and MDA-435/LCC6MDR cells after interna-
lization of pH-sensitive DOX–polymer conjugates: Pink color shows
localization of DOX (red) in nucleus (blue), while yellow color is an
indication of localization of DOX (red) in mitochondria (green) or
endo/lysosomes. Curves showing mice survival and tumor size
evolution for mice treated with DOX–polymer conjugates versus
other groups [208]. B Photographs of phase transitions of PAEU–
PEG–PAEU copolymers with respect to pH or temperature, and hGH
concentration in blood of SD rats after injection of hGH solution, and
hGH-gel formulation [256]. C Scheme depicting concept of pH-
responsive PMPC–PDPA vesicles used for gene transfection and the
cell viability assay and enhanced GFP expression [234]
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(N-isopropylacrylamide)-b-poly(caprolactone) (PNAS-b-
PNiPAAm-b-PCL) triblock copolymer for the delivery of
DOX to HeLa cells. The micelles are internalized in HeLa
cells, and above the LCST of PNIPAAM, i.e. at physio-
logical temperature, 97% of the DOX payload is released.
In targeted drug delivery, it is also of interest to feature
sensitivity towards a specific enzyme. A self-immolative
dendrimer structure for the release of PAX activated by
enzyme was reported [215]. The dendrimer was linked with
an enzyme-responsive moiety to a N-(2-hydroxypropyl)-
methacrylamide (HPMA) polymer for solubilization
enhancement. Upon activation with cathepsin B (a lyso-
somal cystein protease), three PAX molecules were
released. Cell growth inhibition assay using TRAMP-2
cells revealed a clear inhibition of cell proliferation when
compared to controls. Polymeric micelles sensitive to
lysosime were also reported [216].
Ionic interactions were used to deliver drugs, using the
concept of PIC micelles, i.e. structures formed via elec-
trostatic interactions between charged macromolecules and
oppositely charged polymer chains. While conventional
polymer micelles are mainly used for solubilization of
hydrophobic drugs, hydrophilic, charged macromolecules
(i.e. metal complexes, proteins, nucleic acids, and peptides)
can be encapsulated in PIC micelles, and easily released
via addition of counterions or pH switches [172, 217].
Cisplatine, a platinum complex-based anticancer drug, was
bound to the carboxylic acids of poly(glutamic acid), which
acted as ligands for Pt, and the complex was released upon
ligand exchange with chloride ions in the body [218]. The
micelles accumulated in tumor tissues of mice via EPR
effect, leading to complete tumor regression.
Ionic interactions may also mediate the sol–gel transi-
tion of polyelectrolytes. Sol–gel polymers undergo a
reversible gelation caused by a stimulus. They have
application in drug delivery, where they can be formulated
as a solution that embeds drugs, transforming into a gel
when in contact with the body [179]. The drug is then
released by diffusing through the gel, or upon gel degra-
dation in the case of biodegradable polymers. As an
example, alginate polymers containing pilocarpine (an
alkaloid used in the treatment of glaucoma) undergo a sol–
gel transition upon the addition of calcium ions, present
in lachrymal fluid. Eye-drops of an alginate solution
containing pilocarpine showed a significant decrease of
intra-ocular pressure in rabbits over 10 h, due to the diffu-
sion-controlled release of the drug [219]. Thermally induced
gel formation was also reported in an ocular drug delivery
system, with Pluronic and PNiPAAm based systems, for the
delivery of pilocarpine and timolol maleate [220, 221].
4.2.1.2 Protein and Enzyme Delivery The release of
proteins and enzymes is also very challenging. These
biomacromolecules are often fragile and present net char-
ges. Therefore, they need to be shielded from potentially
harmful species in the body, either via encapsulation in the
lumen of polymeric vesicles, or reversible association with
polyelectrolytes to form PIC micelles.
It should be noted that, although the encapsulation (and
subsequent release) of functional proteins into responsive
polymersomes has been demonstrated [116, 222, 223], to
the best of our knowledge the triggered release of a ther-
apeutic protein with demonstrated biomedical applications
has never been shown [174]. Therefore, although poly-
mersomes represent an attractive nanocarrier for protein
delivery, in vivo medical applications are yet to be
reported.
As described previously, the dissociation of PIC
micelles may be triggered through the use of different
stimuli responsive polymers, either via a charge conversion
induced by the addition of counterions or pH change, the
degradation of chemical bonds via pH or a reducing con-
dition, or via temperature changes [224]. Using such
charge conversion, lysozyme was encapsulated in PIC
micelles composed of poly(ethylene glycol)-poly[(N0-citr-
aconyl-2-aminoethyl)aspartamide] (PEG-pAsp(EDACit)).
The PIC micelles degraded in response to the endosomal
pH and released lysozyme [225].
Another approach to controlled drug delivery of proteins
is to use smart surfaces responsive to temperature, chem-
ical stimuli, or electric stimulus. Polymer films grafted on
surfaces are good candidates for drug delivery because they
have high storage and high retention capability, and can
uptake and release biomacromolecules on demand [22]. As
an example, polypyrrole (PPy) offers an opportunity to
build electrically responsive systems. Nerve growth factor
(NGP) was loaded on a polypyrrole conductive film, and
was released upon electrical activation [226]. A similar
system was used to release adenosine triphosphate (ATP)
[227].
Smart polymer films can also be used as stimuli-acti-
vated gates to control release of molecules. The use of
thermo-responsive PNiPAAm as an on–off gate was
reported by Yavuz et al. [228]. PNiPAAm was covalently
attached to gold nanocages via thiolate linkage. Using the
photothermal effect of the gold nanocages, PNiPAAm
underwent reversible conformational changes resulting in
an on–off gating of the pores. The controlled release of
DOX and lysozyme was investigated, and in vitro experi-
ments respectively showed significant decreases in cell
viability after 5 min of irradiation with IR light, and 80%
bioavailabilty of the enzyme.
In situ-forming polymer gels are another class of
materials built of stimuli-responsive polymers and having
great potential in drug delivery. As an example, poly(eth-
ylene glycol) (PEG) and poly(b-amino ester urethane)
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(PAEU) copolymer undergo pH- and temperature-induced
gelation under physiological conditions [229]. These
materials were used to deliver human growth hormone
(hGH) to rats. Results show that the hGH concentration in
the serum of rats was maintained at a higher level than in
the control, due to the controlled release rate obtained with
the gel (Fig. 8B).
4.2.1.3 Gene Delivery The delivery of genes, or gene
therapy, was proven very effective in the treatment of
several diseases. As with proteins and enzymes, the
transport of DNA into a cell is a difficult process, because
of the charge and size of such molecules. Therefore, the
need for gene carriers that can safely and effectively
administer these materials in vivo is growing.
A method of choice is to use PIC micelles. As described
above, these structures can help the vectorization of
charged macromolecules using polyelectrolytes. Plasmid
DNA complexed with a a-lactosyl-poly(ethylene glycol)-
poly(2-(dimethylamino)ethyl methacrylate) block copoly-
mer (lactose–PEG–PAMA) was efficiently transfected to
HepG2 cells [230]. Another example of PIC micelles was
reported by Xiong et al. [231], where siRNA was delivered
to metastatic human MDA435/LCC6 cancer cells, and
efficient gene silencing was observed.
Recently, an example of a block copolymer for gene
delivery bearing a pH-sensitive linkage between hydro-
philic and hydrophobic segments was reported. The
poly[(2-dimethylamino)ethyl methacrylate] (PDMAEMA)
and PEG blocks are connected via an ortho-ester, which
can be cleaved upon pH-triggering [232]. Transfection
efficiency was proven with the encapsulation of luciferase
and EGFP gene expression plasmids, and their pH-trig-
gered release in the endosome of 293T cells.
An example of an instantaneously pH-responsive poly-
mer vesicle was described by Armes and coworkers [233].
They developed a highly biocompatible and pH-sensitive
block copolymer, poly[2-(diisopropylamino)ethyl methac-
rylate]-poly[2-(methacryloyloxy)ethyl phosphorylcholine]
(PDPA-PMPC). The PDPA block is deprotonated and
insoluble at pH above 7 (pKa around 5.8–6.6). Water-sol-
uble doxorubicin was encapsulated within PDPA–PMPC
vesicles, and released upon lowering the solution pH. The
system also proved useful for the physical encapsulation
and intracellular delivery of GFP-encoding DNA plasmid
[234, 235]. As shown in Fig. 8C, superior GFP expression
is obtained with the polymer vesicles when compared to
Lipofectamine TD and calcium phosphate.
Polypeptide-based block copolymers also show tem-
perature induced conformal changes, from a-helical to
b-sheets structures. As an example, polymersomes built of
PLL-b-PBLG-d7-b-PLL have been synthesized, where
PLL and PBLG-d7 are poly(L-lysine hydrochloride) and
poly(c-benzyl-d7-L-glutamate), respectively [236]. In vitro
encapsulation and release of plasmid DNA was shown.
In an example of structures similar to polymer–drug
conjugates by Oishi et al. [237], micelles in which the
corona-forming block itself is a therapeutic agent have
been synthesized. The oligonucleotides, connected to the
hydrophobic block with a pH-sensitive spacer, were
released upon pH change.
As emphasized in several reviews, dendrimers are also
very useful as transfection vectors, for different DNA
molecules [210, 238, 239].
4.2.2 Regenerative Medicine
Stimuli-responsive polymers also find application in
regenerative medicine. In this regard, they can be classified
into polymers for the design of smart surfaces, and poly-
mers that undergo sol–gel transitions for injectable
implants. Smart surfaces may be used as supports or
scaffolds, with excellent controllability of surfaces prop-
erties, that can, in turn, be used for adsorption and
desorption of biomacromolecules and cells. It is known that
cell behavior and attachment is greatly influenced by the
wettability of a surface, and that biomacromolecules have
higher affinity for hydrophobic surfaces. Therefore,
depending on the application, stimuli-responsive polymers
grafted on surfaces provide possibilities to design scaffolds
for tissue engineering.
4.2.2.1 Smart surfaces for tissue engineering Cells in
tissues grow in a rather complex fashion, surrounded by an
extracellular matrix (ECM) that plays an essential role as a
support. In addition, ECM elicits a wide range of biological
signals and releases various biological factors, controlling
both cell behavior and proliferation. In order to build viable
cell sheets for tissue engineering, synthetic materials
should mimic functionalities, similar to ECM. Thus, the
use of stimuli-responsive polymers to design smart surfaces
as ECM biomimetic materials to be used as scaffolds for
the growth of new cells and tissue engineering is currently
a fast growing research area. In order to advantageously
replace other existing materials and allow the growth and
proliferation of cell sheets, smart surfaces should display
reversible changes in their affinity for biomolecules and
their cell adhesion properties, as well as provide sustained
release of biomacromolecules.
Although polymer substrates have been used previously
in cell culture (with polystyrene, for instance), the use of
stimuli-responsive polymers represents a gentler alternative
to mechanical or enzymatic digestion (protease) for cell
detachment procedures needed in these systems. It guar-
antees the collection of intact cell sheets using a non-
invasive cell recovery method, and these cell sheets can
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then be implanted in the body for tissue engineering
applications.
As an example, thermo-responsive polymer films have
been shown to be very useful in the control of cell recog-
nition, adhesion and detachment. In this field, pioneering
work was performed by Okano et al. [133, 240, 241] using
PNiPAAm as the thermo-responsive polymer. Various
cells, including hepatocytes, endothelial cells, fibroblasts,
keratinocytes, epithelial cells, macrophages, and microglial
cells, adhere and proliferate on such surfaces. When tem-
perature is lowered under the LCST of PNiPAAm, the
surface gradually switches from hydrophobic to hydro-
philic, leading to cell desorption, without the need to use
EDTA or trypsin [242].
In order to improve selective cell adhesion, biologically
active moieties have been integrated into smart surfaces.
As an example, dynamic surfaces controlling the presen-
tation of recognition and regulatory signals were investi-
gated [243]. In these systems, immobilized RGD sequences
promote cell adhesion, and are shielded upon lowering
temperature.
As mentioned earlier, the immobilization and pro-
grammed release of biologically active agents is desirable
in order to promote cell adhesion and direct cell behavior.
Such molecules can be hosted on smart surfaces via elec-
trostatic interactions, conjugation, or encapsulation.
Release of proteins was shown using ionic strength-sensi-
tive [244] and thermo-responsive systems [245–250].
Even though temperature responsive surfaces based on
PNiPAAm have been studied the most, other stimuli have
also been investigated, such as light and electrical signals.
Nerve regeneration is crucial, because it is very difficult to
reconnect severed nerves by surgical means. The use of
electro-responsive surfaces based on conductive polypyrol
(PPy) was explored, and PC-12 as well as chicken sciatic
nerve explants were shown to grow and proliferate pref-
erentially on PPy surfaces submitted to an electric stimulus,
when compared to controls [251].
Light was used with spiropyran-based polymers to
efficiently detach cells from surfaces in a reversible manner
[145]. Platelets and mesenchymal stem cells were shown to
adhere to a poly(nitrobenzospiropyran)-poly(methyl meth-
acrylate) copolymer, where the photo-sensitive groups are
in a closed, non-polar spiropyran isomer conformation
(hydrophobic surface). Upon UV irradiation, the spiropy-
ran is converted to a zwitterionic merocyanine isomer,
facilitating cell detachment (hydrophilic surface). Inter-
estingly, light activated systems allow the manipulation of
cell sheets, via the selective irradiation of a given region,
thus creating patterns (Fig. 9A) [144].
Another application of smart surfaces is the controlled
fabrication of biomimetic ceramics. Recently, a thermo-
responsive surface built of PLA and Bioglass with grafted
PNiPAAm showed an interesting application in biominer-
alization. The production of bonelike apatite is of prime
interest for regeneration and tissue engineering, especially
for orthopedic applications. In their work, Shi et al. [252]
showed that calcification could be controlled by tempera-
ture, and yielded apatite material with bone-like structure.
4.2.2.2 Sol–Gel Transition Polymers as Injectable
Implants Most of these systems are used exclusively for
in vitro cell cultures, followed by cell desorption: for in
vivo use, surgery must be performed to implant the cell
sheets. To avoid this, a class of materials known as
injectable implants is used. These systems are based on the
gelation of a polymer solution upon injection into the body,
and can promote cell delivery or other useful therapeutic
agents such as growth factor.
The basis for using injectable polymers is that the matrix
temporarily replaces damaged tissue, allowing proliferation
and growth of cells until a new cell sheet or extracellular
matrix is produced on site. Among the physiological
stimuli used for gelling, temperature is the most studied
and the most advantageous for in vivo application, due to
its ease of use. Chitosan–PNiPAAm copolymer-forming
gels have been employed as thermo-responsive injectable
nanogels as scaffolds for tissue engineering [253, 254].
Mesenchymal stem cells embedded in the copolymer
solution were able to differentiate into chondrocytes (cells
found in cartilaginous matrix) in vitro (Fig. 9B). The cell–
polymer mixture was injected into rabbit bladders, where
the formation of new cartilage on the polymer matrix was
detected [253]. Another thermo-responsive in situ forming
gel based on chitosan and Pluronic polymers was shown to
exhibit superior haemostatic properties [255].
5 Summary and Conclusions
Progress in medicine today relies on the advent of new
systems and approaches that serve to detect pathological
events in early stages, permit precise, safe surgery, and
treat a specific region efficiently with minimal side effects.
In this respect, stimuli-responsive systems are of particular
interest. Stimuli-responsiveness represents a key property
in medical applications because it serves to allow for
controllable response from biological compartments, such
as the release of an encapsulated/entrapped active com-
pound, the triggering of a signaling process, or the detec-
tion of a specific biomolecule. A variety of systems that are
intended to response to stimuli or a combination of stimuli
has been developed based on polymers. There are two
possible ways to obtain responsiveness: by using an SR
polymer or by using a stimuli-responsive compound com-
bined with a non-responsive polymer serving as a template.
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Stimuli-responsive polymers represent a smart, synthetic
way to mimic the behavior of biopolymers, such as pro-
teins, that undergo drastic conformational change at a
critical point while remaining stable over a wide range of
environmental conditions. Here, we have focused on
stimuli-responsive polymers and have indicated both the
variety of changes to physical, chemical and biological
stimuli, and the possible medical applications. The
response of a given polymer is based either on a dramatic
alteration of its structure or on a change in its properties,
such as charge, solubility, or polarity. An alteration to the
polymer structure takes place when the polymer is degra-
ded by breaking chemical bonds in the backbone or at
specific positions where cross-linking moieties are inserted
in its structure for this purpose. The change in properties is
achieved by introducing functional groups that support or
even induce changes in chain dimension, secondary
structure or supramolecular assembly architecture. Chan-
ges in properties are mediated by changes in intermolecular
interactions, by undergoing a specific chemical reaction, or
by the presence of modified physical conditions.
A large variety of SR polymer-based systems has been
developed, both in solution and on solid support, to serve
diagnostic and therapeutic purposes. In solution, various
architectures have been introduced, ranging from dendri-
mers to supramolecular assemblies generated by the self-
assembly of amphiphilic copolymers, such as micelles and
vesicles. On solid support, polymer mono- and multilayers
undergo a change in properties as a response to an external
stimulus and thus generate smart, active surfaces—espe-
cially important in biosensing approaches. However, the
multitude of polymer systems and assemblies is dramati-
cally reduced when medical application is intended, due to
the complex requirements related to use inside the body. In
this respect only SR polymers that are biocompatible and
biodegradable can be used without toxicity problems. In
addition, size, charge, flexibility, and shape of supramo-
lecular assemblies are properties that should be modulated
so as to allow for an optimum administration route and
simultaneous high efficacy. Multifunctionality is another
key factor that serves to increase the potential of polymer
systems in medical applications in terms of developing
Fig. 9 A Manipulation of CHO-K1 cell sheets with UV irradiation
and temperature: microscopic images of photoresponsive culture
surface before (left) and after (middle) regional UV irradiation
followed by the low-temperature washing, and after second regional
UV irradiation followed by the low-temperature washing (right).
Yellow rectangles indicate UV-irradiated regions [144]. B SEM
pictures of injectable nanogels formed by chitosan–PNiPAAm
copolymers (left): SEM micrographs of chitosan–PNiPAAm hydrogel
scaffold and hydrogel scaffold after temperature cycling between 25
and 37C 100 times (up), chondrocytes and meniscus cells cultured in
chitosan–PNiPAAm hydrogel scaffolds for 21 days (bottom) [254]
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targeting approaches, or theragnostic strategies. We have
presented various medical applications here, in which SR
polymer systems represent ideal candidate systems, starting
with diagnostic approaches and extending to therapeutic
treatment and tissue regeneration. However, using SR
polymer systems/assemblies at the nanometer scale is an
emerging field that will benefit greatly from more and
extended studies on biodisposability, biodistribution, and
toxicity in order to provide safe solutions and improve a
patient’s condition. The modulation of polymer properties
for an efficient response to a stimulus represents an
important parameter that must be adjusted in medical
applications, but must always take into account the overall
behavior of the system as it copes with the challenges
presented under biological conditions, especially inside the
body.
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